CURZA

Cūrza is a small-molecule therapeutics company that has developed several structurally distinct classes of proprietary drugs focused on infectious diseases... Cūrza's goal is to develop novel classes of antibiotics that combat the rising epidemic of antibiotic resistance that now contributes to the death of 5,000,000 people each year... Our lead program, CZ-02 is a new class of broad spectrum antibiotics, focused on ESKAPE pathogens, with a focus on drug-resistant Gram-negative bacteria. Inspired by a natural product, this class targets an unexploited binding site of the bacterial ribosome.

Also known as: Cūrza

Primary location: Salt Lake City United States